Documents

217 documents

Enter search criteria

Fill in keyword(s) to narrow your search.

Period

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a document or publication you are looking for, such as press releases or speeches.

Subscribe to the latest documents

Assessment report Allanblackia seed oil, applicant Unilever

A report on the initial assessment of Allanblackia seed.

Report | 17-12-2017

Overview of withdrawals following consideration of patients’ interest 2017

Overview of withdrawals following consideration of patients’ interest 2017 states for which medicinal products the marketing ...

Publication | 22-09-2017

Assessment report UV-treated mushrooms

A report on the initial assessment of UV-treated mushrooms  by the applicant companies, Banken Champignons Groep BV and JK ...

Report | 20-09-2017

MEB 6: Labelling of pharmaceutical products

The presentation of the primary and secondary packaging of a medicinal product are determining factors in the recognition of a ...

Policy document | 23-08-2017

MEB 5: Package leaflet of pharmaceutical products

This policy document explains the policy regarding the package leaflet of pharmaceutical products in the Netherlands. Download ...

Policy document | 23-08-2017

MEB 27: MEB commentary on the ‘Guideline on Summary of Product Characteristics’

This document serves as a commentary on the ‘Guideline on Summary of Product Characteristics’. Download this policy document in ...

Policy document | 23-08-2017

Assessment report Chia seed, applicant Bravo Foods B.V.

A report on the assessment of chia seed by the company Bravo Foods B.V. for substantial equivalence to chia seed, which has ...

Report | 19-06-2017

Assessment report DHA-rich algal oil, applicant Changsha Sunnycare Inc.

A report on the assessment of DHA-rich algal oil by the company Changsha Sunnycare Inc for substantial equivalence to DHA-rich ...

Report | 14-06-2017

Assessment report chondroitine sulphate, applicant Gnosis S.p.A.

A report on the initial assessment of chondroitine sulphate by the company Gnosis S.p.A.

Report | 23-05-2017

Empty SPC template – QRD 8.1 (MRP/DCP/national)

Form | 15-05-2017